Skip to main content

Table 4 Psychotropic medications in the depression training and testing samples

From: Using heart rate profiles during sleep as a biomarker of depression

  Training sample n (%) Testing sample n (%)
Any psychotropic medication 542 (81.6) 69 (79.3)
 SSRI 239 (36.0) 28 (32.2)
 SNRI 190 (28.6) 19 (21.8)
 TCA 39 (5.9) 6 (6.9)
 NaSSA 43 (6.5) 2 (2.3)
 MAOI 4 (0.6) 1 (1.1)
 NRI/NARI 5 (0.8) 1 (1.1)
 SARI 119 (17.9) 25 (28.7)
 NDRI 89 (13.4) 12 (13.8)
 RIMA 6 (0.9) 1 (1.1)
 Other antidepressant 0 (0.0) 0 (0.0)
 Antipsychotic 126 (19.0) 0 (0.0)
 Mood stabilizer 71 (10.7) 8 (9.2)
 Lithium 17 (2.6) 3 (3.4)
 Melatonin agent 15 (2.3) 1 (1.1)
 Benzodiazepine 96 (14.5) 8 (9.2)
 Hypnotic/Sedative/Anxiolytic 123 (18.5) 2 (2.3)
 Stimulant 38 (5.7) 4 (4.6)
 Dopamine agonist 1 (0.2) 3 (3.4)
 NMDA receptor antagonist 0 (0.0) 1 (1.1)
 Acetylcholinesterase inhibitor 1 (0.2) 0 (0.0)
  1. SSRI Selective Serotonin Reuptake Inhibitor, SNRI Serotonin-Norepinephrine Reuptake Inhibitor, TCA Tricyclic Antidepressant, NaSSA Noradrenergic/Specific Serotonergic Antidepressant, MAOI Monoamine Oxidase Inhibitor, NRI/NARI Noradrenergic Reuptake Inhibitor, SARI Serotonin Antagonist and Reuptake Inhibitor, NDRI Norepinephrine-Dopamine Reuptake Inhibitor, RIMA Reversible Monoamine Oxidase Inhibitor